Baird Starts Optimer Pharmaceuticals (OPTR) at Outperform, $16 PT

February 6, 2013 5:41 PM EST Send to a Friend
Get Alerts OPTR Hot Sheet
Price: $12.78 --0%

Rating Summary:
    4 Buy, 9 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 28 | New: 51
Trade OPTR Now!
Join SI Premium – FREE
Baird initiates coverage on Optimer Pharmaceuticals (NASDAQ: OPTR) with a Outperform. PT $16.00.

"We expect Dificid sales volume to continue a linear, long-term growth trajectory, but in the near term be aided by the elevation of influenza in the US this season," analyst Christopher Raymond said. "Although concerns around pricing have led to controversy around the commercial opportunity, we believe the steady increase in market share is a reason to be optimistic that the recent pressure on shares is unwarranted."

For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.

Shares of Optimer Pharmaceuticals closed at $10.33 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Robert W Baird

Add Your Comment